Vivos (RDGL) FCF Margin Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1,716.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,833.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 192.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 261.00 |
| 10 | Vivos | - | - | -3,105.00 | 724,783.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 724,783.00 |
| Sep 30, 2025 | -1.43 Mn |
| Jun 30, 2025 | -139,739.00 |
| Mar 31, 2025 | 610,838.00 |
| Sep 30, 2024 | -695,481.00 |
| Jun 30, 2024 | 220,329.00 |
| Mar 31, 2024 | -291,643.00 |
| Sep 30, 2023 | 118,312.00 |
| Jun 30, 2023 | -320,626.00 |
| Mar 31, 2023 | -193,761.00 |
| Sep 30, 2022 | -315,725.00 |
| Sep 30, 2021 | 143,124.00 |
| Sep 30, 2020 | -31,539.00 |
| Mar 31, 2018 | 659,402.00 |
| Mar 31, 2017 | 726,189.00 |
| Sep 30, 2016 | 7.83 Mn |
| Mar 31, 2016 | -1.19 Mn |
| Mar 31, 2015 | 85,950.00 |
| Mar 31, 2014 | -82,251.00 |
| Sep 30, 2013 | 68,063.00 |
| Mar 31, 2013 | -180,528.00 |
| Dec 31, 2012 | 19,150.00 |
| Sep 30, 2012 | -60,901.00 |
| Jun 30, 2012 | -56,635.00 |
| Mar 31, 2012 | -18,208.00 |
| Dec 31, 2011 | -13,120.00 |